TipRanks
Go Ultimate55% OFF

Ag Growth International (7AG) AI Stock Analysis

DE:7AG

Ag Growth International

(Frankfurt:7AG)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Broad agricultural infrastructure portfolioAGI serves several essential stages of the agricultural and food value chain rather than relying on one equipment category. Its combination of storage, handling, conditioning, and processing products can support cross-selling and make the business relevant to customers’ ongoing infrastructure needs.
Negative Factors
Very high leverage and shrinking equityThe high debt burden leaves AGI with a thin equity cushion and materially reduces financial flexibility. Shrinking equity and negative recent returns increase the consequences of operating weakness, while substantial leverage can constrain investment, capital allocation, and the ability to absorb further setbacks.

Ag Growth International (7AG) vs. iShares MSCI Germany ETF (EWG)

-100%-80%-60%-40%-20%0%20%DE:7AG-71.69%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 175.59M
Dividend Yield
6.32%
Average Volume (3M)
21
Price to Earnings (P/E)
-1.5
Beta (1Y)
0.48
Revenue Growth
-4.79%
EPS Growth
-1285.39%
Country
Germany
Employees
3,679
Sector
Industrials
Sector Strength
63
Industry
Agricultural - Machinery

Ag Growth International Business Overview & Revenue Model

Company Description

Ag Growth International Inc. (AGI), through its subsidiaries, is a global manufacturer and distributor of equipment for the handling, storage, and conditioning of grain and rice. The company operates extensively across Canada, the United States, and...

Ag Growth International Earnings Call Summary

Earnings Call Date:Mar 24, 2026(Q4-2025)|% Change Since:-62.26%|Next Earnings Date:Mar 24, 2026
Earnings Call SentimentNegative

The call mixed modest revenue growth and international/commercial topline strength with material operational and financial setbacks. Management disclosed significant margin compression (~830 bps), a large negative free cash flow outflow (~$111M in 2025), elevated leverage (4.7x), and execution failures—notably in Brazil—while outlining a clear restructuring plan, $20M+ annualized SG&A savings, ERP termination to preserve cash, and expectation to monetize $80–$100M of receivables to improve liquidity. The initiatives are constructive but the magnitude and immediacy of the profit, cash and leverage issues indicate significant near-term risk.

Positive Updates

Revenue Growth in Q4
Consolidated Q4 revenue increased 4% year-over-year to $396 million, driven by strength in the Commercial segment and international markets.

Negative Updates

Significant EBITDA and Margin Compression
Adjusted EBITDA decreased ~38% year-over-year to approximately $48.3 million in Q4; adjusted EBITDA margin compressed to 12.2%, a decline of roughly 830 basis points versus prior year.

Company Guidance

Management said Q4 revenue was $396M (+4% YoY) with adjusted EBITDA of approximately $48M (‑38% YoY) and an adjusted EBITDA margin of 12.2% (down ~830 bps); segment detail: Farm Q4 revenue $123M (‑8% YoY; Canada ‑34%, U.S. +11%, International +36%) with Farm adj. EBITDA $19.8M (‑39%, 16% margin vs 24.1% prior), and Commercial Q4 revenue $273M (+10%; international $206M, +18%) with Commercial adj. EBITDA $33M (‑39%, 12% margin vs 21.6% prior). They closed 2025 with an order book of $543M (‑26% YoY), negative free cash flow of ~$111M for 2025, net debt leverage 4.7x (vs 3.9x q/q, 3.1x y/y), and disclosed a $21M transactional expense in Q4; management expects negative FCF in Q1 but plans to monetize Brazil receivables (already $7M received, targeting $80–100M by H1) to materially improve cash flow. Near-term actions: terminate the ERP, suspend the dividend, reduce the executive team from 17 to 8 and complete North America realignment in ~30 days, drive at least $20M of annualized SG&A savings and ~$20M of cash cost avoidance over two years, incur ~ $20M of one‑time costs in H1, pause new large-scale financed projects (equipment‑only in Brazil only), refinance the dec‑maturity debenture in Q2–Q3, and target returning to historical margins (but not near‑term 18–20% levels) while pursuing a longer‑term leverage target of ~2.5x.

Ag Growth International Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:7AG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:DRXTSE:DRX69NeutralCAD 466.56M12.8716.61%0.24%29.57%-7.54%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
TSE:DCMTSE:DCM62NeutralCAD 137.65M28.0210.60%4.55%-4.58%-36.77%
TSE:ANRGTSE:ANRG55NeutralCAD 325.93M20.66-29.88%―101.45%―
TSE:VLNTSE:VLN45NeutralCAD 374.29M-10.54-14.80%3.23%-9.05%73.48%
TSE:TBLTSE:TBL44NeutralCAD 392.92M13.579.04%―-5.27%-37.28%

* Industrials Sector Average

Performance Comparison

-50%0%50%100%150%DE:7AGTSE:DCMTSE:DRXTSE:TBLTSE:VLNTSE:ANRGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:7AG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:7AGAg Growth International5.85-15.61-72.74%
TSE:DCMData Commun Management2.200.9576.14%
TSE:DRXADF Group Inc. SV16.349.22129.37%
TSE:TBLTaiga Building Prod3.640.195.51%
TSE:VLNVelan Inc. SV17.340.613.62%
TSE:ANRGAnaergia, Inc.1.87-0.56-23.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.